Per Falholt assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As Chief Science Officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth. Mr Falholt started his career in Novo as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director of Application Technology in the company’s new enzyme development division in 1995. In April 2000, Per Falholt merged the Research and Development division into the newly formed Enzyme Business Research and Development.
Join our Opinion Leaders Panel
Complete the form to join our panel and receive rewards every time you complete our business surveys. You will also receive the weekly newsletter, containing the latest cutting edge reports, blogs and industry data.